[News Article]PharmAbcine`s ``BI(Business Incubation) Research Grant`` proposal is granted by KIAT.

14 Jan 2019
Title
PharmAbcine`s ``BI(Business Incubation) Research Grant`` proposal is granted by KIAT.
Category
News Article


PharmAbcine`s "BI(Business Incubation) Research Grant" proposal is granted by KIAT (https://www.kiat.or.kr/site/main/main.jsp) and PharmAbcine will use this research funding to generate the second generation of PMC-001(DIG-KT) to get ready to out-license. 

The first generation version of PMC-001(DIG-KT) has been out-licensed to 3SBio for both Korea and China market in 2015.The CEO and CFO of PharmAbcine are going to participate the BI Research Grant workshop organized by KIAT and will have 1-to 1 partnering meetings with investors and business partners on July 13-14, 2017.

 

Reference:

 

http://www.prnewswire.com/news-releases/3sbio-signs-exclusive-patent-license-agreement-for-dig-kt-a-bi-specific-mab-targeting-vegfr2-and-tie-2-with-pharmabcine-300020495.html

 

http://bciq.biocentury.com/products/dig-kt

 

http://whosaeng.com/sub_read.html?uid=71563

 

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499296/

 

http://eng.kddf.org/bbs/bbs.asp?mode=view&IDX=717&p=1&cateId=35

 

http://www.worldbil.com/CTIP2015/Download/8.pdf




     2F, Research Building 2, 70,

     Yuseong-daero 1689 beon-gil,
     Yuseong-gu, Daejeon, 34047, Republic of Korea


     HQ +82-42-863-2017 

     R&D Center +82-42-861-2017

     Investor Relations +70-4294-6097 

     FAX +82-42-863-2080 


     COPYRIGHT BY PharmAbcine Inc.

     ALL RIGHTS RESERVE